MPM Bioimpact LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
MPM Bioimpact LLC disclosed 43 US equity positions worth $666.6m in its Q3 2024 13F filing. The largest position was CGEM at 19.2% of the reported book, followed by INSM and OLMA.
What did MPM Bioimpact LLC own in Q3 2024? Top 43 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | CGEM Cullinan Therapeutics, Inc. | Healthcare | 19.2% | $128.0m | 7,648,268 | – | |
| 2 | INSM Insmed Incorporated | Healthcare | 6.7% | $44.9m | 615,391 | – | |
| 3 | OLMA Olema Pharmaceuticals, Inc. | Healthcare | 4.8% | $32.0m | 2,680,596 | – | |
| 4 | RNAGBP Avidity Biosciences Inc | 4.7% | $31.6m | 688,975 | – | ||
| 5 | CRNXGBP Crinetics Pharmaceuticals Inc. | 4.0% | $26.9m | 525,845 | – | ||
| 6 | EWTX Edgewise Therapeutics Inc | 3.7% | $24.5m | 917,166 | – | ||
| 7 | IOVA Iovance Biotherapeutics Inc | Healthcare | 3.4% | $22.6m | 2,406,714 | – | |
| 8 | NTRA Natera Inc | Healthcare | 3.4% | $22.5m | 177,099 | – | |
| 9 | RCKT Rocket Pharmaceuticals, Inc. | Healthcare | 3.0% | $19.7m | 1,066,373 | – | |
| 10 | MIRM Mirum Pharmaceuticals Inc | Healthcare | 2.9% | $19.2m | 492,723 | – | |
| 11 | RARE Ultragenyx Pharmaceutical Inc | Healthcare | 2.7% | $18.3m | 329,733 | – | |
| 12 | 2662247D iTeos Therapeutics, Inc. | 2.7% | $17.8m | 1,745,943 | – | ||
| 13 | MLTX Moonlake Immunotherapeutics | Healthcare | 2.6% | $17.6m | 349,063 | – | |
| 14 | LNTH Lantheus Holdings Inc | Healthcare | 2.5% | $16.5m | 150,182 | – | |
| 15 | MDGL Madrigal Pharmaceuticals Inc | Healthcare | 2.3% | $15.4m | 72,395 | – | |
| 16 | IRON Disc Medicine Inc | Healthcare | 2.3% | $15.3m | 311,761 | – | |
| 17 | RLAY Relay Therapeutics Inc. | Healthcare | 2.2% | $14.4m | 2,033,041 | – | |
| 18 | TWST Twist Bioscience Corp | Healthcare | 2.0% | $13.3m | 294,930 | – | |
| 19 | RVMD Revolution Medicines, Inc. | Healthcare | 2.0% | $13.2m | 291,391 | – | |
| 20 | GH Guardant Health Inc | Healthcare | 1.7% | $11.5m | 499,170 | – | |
| 21 | Akero Therapeutics Inc | 1.7% | $11.3m | 392,544 | – | ||
| 22 | 4XC1 Kalvista Pharmaceuticals Inc | 1.6% | $10.4m | 896,915 | – | ||
| 23 | CMPX Compass Therapeutics, Inc. | 1.6% | $10.4m | 5,641,894 | – | ||
| 24 | RNAC Cartesian Therapeutics Inc | 1.5% | $10.1m | 629,423 | – | ||
| 25 | STRO Sutro Biopharma, Inc. | Healthcare | 1.5% | $9.8m | 2,832,064 | – | |
| 26 | AQST Aquestive Therapeutics Inc | 1.3% | $8.9m | 1,796,750 | – | ||
| 27 | JANX Janux Therapeutics Inc | Healthcare | 1.2% | $7.8m | 171,105 | – | |
| 28 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.1% | $7.7m | 120,982 | – | |
| 29 | XENE Xenon Pharmaceuticals Inc | Healthcare | 1.0% | $6.5m | 165,800 | – | |
| 30 | STOK Stoke Therapeutics Inc | Healthcare | 0.9% | $5.9m | 479,452 | – | |
| 31 | RPTX Repare Therapeutics, Inc. | 0.8% | $5.6m | 1,639,849 | – | ||
| 32 | NTLA Intellia Therapeutics, Inc. | Healthcare | 0.8% | $5.5m | 267,557 | – | |
| 33 | ZNTL Zentalis Pharmaceuticals, Inc. | Healthcare | 0.8% | $5.4m | 1,465,801 | – | |
| 34 | TRVI Trevi Therapeutics Inc | Healthcare | 0.8% | $5.1m | 1,538,517 | – | |
| 35 | WVE Wave Life Sciences PTE LTD | Healthcare | 0.8% | $5.1m | 624,471 | – | |
| 36 | ARCT Arcturus Therapeutics Holdings | Healthcare | 0.8% | $5.1m | 219,508 | – | |
| 37 | HOWL Werewolf Therapeutics, Inc. | 0.8% | $5.1m | 2,388,011 | – | ||
| 38 | ADAPY Adaptimmune Therapeutics plc | Healthcare | 0.7% | $4.8m | 5,095,912 | – | |
| 39 | ALXO ALX Oncology Holdings Inc. | Healthcare | 0.7% | $4.4m | 2,409,862 | – | |
| 40 | PTCT PTC Therapeutics Inc | Healthcare | 0.5% | $3.3m | 89,715 | – | |
| 41 | ETNBGBP 89Bio Inc | 0.4% | $2.4m | 330,000 | – | ||
| 42 | RGNX REGENXBIO Inc. | Healthcare | 0.1% | $524.5k | 50,000 | – | |
| 43 | SLDB Solid Biosciences Inc | Healthcare | 0.0% | $80.3k | 11,518 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.